Nouroz Sehar
Overview
Explore the profile of Nouroz Sehar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rehman M, Sehar N, Rasool I, Aldossari R, Wani A, Rashid S, et al.
Int J Geriatr Psychiatry
. 2024 Jun;
39(6):e6104.
PMID: 38877354
The central nervous system (CNS) is widely recognized as the only organ system without lymphatic capillaries to promote the removal of interstitial metabolic by-products. Thus, the newly identified glymphatic system...
2.
Patwekar M, Sehar N, Patwekar F, Medikeri A, Ali S, Aldossri R, et al.
Int Immunopharmacol
. 2023 Nov;
126:111186.
PMID: 37979454
The immune system frequently comprises immunological checkpoints. They serve as a barrier to keep the immune system from overreacting and damaging cells that are robust. Immune checkpoint inhibitors (ICIs) are...
3.
Tariq L, Arafah A, Sehar N, Ali A, Khan A, Rasool I, et al.
Med Oncol
. 2023 Aug;
40(10):282.
PMID: 37639075
Colorectal cancer (CRC) is the third highest frequent malignancy and ultimate critical source of cancer-associated mortality around the world. Regardless of latest advances in molecular and surgical targeted medicines that...
4.
Noor A, Shafi S, Sehar N, Qadir I, Bilquees , Rashid S, et al.
Curr Med Chem
. 2023 Aug;
31(21):3093-3117.
PMID: 37559247
Despite substantial advancements in curative modern medicine in the last few decades, cancer risk and casualty rates have continued to mount globally. The exact reason for cancer's onset and progression...
5.
Rehman M, Sehar N, Dar N, Khan A, Arafah A, Rashid S, et al.
Neurosci Biobehav Rev
. 2022 Nov;
144:104961.
PMID: 36395982
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease (PD), and Huntington disease (HD) represent a major socio-economic challenge in view of their high prevalence yet poor treatment outcomes...
6.
Khan M, Bhurani D, Hoda U, Sehar N, Agarwal N
Arq Neuropsiquiatr
. 2022 Oct;
80(8):786-793.
PMID: 36252586
Background: Anthracyclines-based regimen (5-fluorouracil, doxorubicin, and cyclophosphamide (FAC); cyclophosphamide, epirubicin, and 5-fluorouracil [CEF]) and non-anthracycline based regimens (cyclophosphamide, methotrexate, and 5-fluorouracil [CMF]) are widely used as neoadjuvant chemotherapy for breast...
7.
Parveen R, Sehar N, Bajpai R, Agarwal N
Diabetes Res Clin Pract
. 2020 Jul;
166:108295.
PMID: 32623032
Aim: The novel coronavirus infection (COVID-19), now a worldwide public health concern is associated with varied fatality. Patients with chronic underlying conditions like diabetes and hypertension have shown worst outcomes....
8.
Sehar N, Agarwal N, Vohora D, Raisuddin S
Epilepsy Behav
. 2014 Dec;
42:48-53.
PMID: 25499163
Purpose: Atorvastatin (ATV) is widely used for the treatment of dyslipidemias. Recent evidence has shown that ATV has protection effects against seizures. However, the effect of ATV on certain neurotransmitter...